Named supply, never blended
Every respondent is attributed to the supplier who sourced them, respondent by respondent. You see who is fielding your study, which means a quality problem always has an owner.
Use cases · Open Network
For healthcare and specialist teams this is where the work starts, and for everyone else it is the brief they had to decline. Rare cohorts are scattered thin across dozens of suppliers, so the buyer who asks only their usual three gets told “not feasible” about people who demonstrably exist.
Three products, one job
All three work alone. Which one you reach for first depends on who you are and what is breaking.
Rheumatology nurses in tier-2 cities. CFOs at sub-500-employee firms. Owners of one specific device. None of these cohorts live inside a single panel. They sit in ones and twos across dozens of suppliers, most of whom you have never had a reason to call.
So the brief comes back declined, and the reason given is feasibility when the real reason is roster size. The audience was always reachable. It was never reachable from three phone numbers.
The usual fix makes a different trade. A marketplace buys reach by blending supply and taking the names off it, which works right up until quality slips and there is no named source to hold accountable for it.
Rheumatology nurses · tier-2 cities
Quoted: not feasibleSupplier A
14
Supplier B
9
Supplier C
4
Supplier D
22
Supplier E
17
Supplier F
11
Supplier G
8
Illustrative distribution. No single supplier closes the cohort. Four of them together do, and three of those four were never on the list the feasibility answer was based on.
The Open Network is a directory of sample suppliers whose standing is built from observed fieldwork rather than from a capabilities deck, open to your RFQ the moment your own network is not enough.
Every respondent is attributed to the supplier who sourced them, respondent by respondent. You see who is fielding your study, which means a quality problem always has an owner.
Traditional vetting is a capabilities deck, a compliance form and two references, identical for every prospect. A network standing is built from what actually happened on studies that fielded.
IR accuracy against quoted incidence, term-rate health, quality flags per thousand entrants, delivery reliability against committed dates, billing accuracy, and responsiveness from RFQ to quote.
A profile reads “building record” until enough studies have fielded to be meaningful, and “dormant record” after a long gap. Performance is benchmarked within bands of similar study difficulty, so specialists are neither flattered nor punished.
SoftSight takes no commission, placement fee or margin from transactions the network influences. A marketplace rating routes volume through a pool the platform monetises. These standings have no revenue to serve except being right.
Rates negotiated by anyone stay invisible to every other party. Your studies, clients and audiences are never disclosed to suppliers beyond the RFQs you choose to send them.
The Open Network is in its founding phase, which is why supplier profiles show a record state rather than a marketing claim. If you field sample and want to be in it, the supplier application takes about eight minutes and is read by a person.
One problem, felt differently depending on where you sit. An agency meets it as a brief it has to decline, a specialist team as an audience that exists nowhere in one place, an insights lead as a methodology they will have to defend.
A study needs a low-incidence specialist cohort no single panel can close. The network surfaces combined feasibility across every vetted supplier who holds any part of it, which turns a declined brief into a winnable one without you running a discovery project first.
Rheumatology nurses in tier-2 cities, or a rare-condition patient cohort, exist in no single panel. Reach gets assembled across named suppliers who each hold a part of the population, so the study happens rather than getting quoted as impossible.
A multi-market tracker needs consistent supply across forty countries, or across B2B categories thin enough that each one is its own sourcing exercise. Instead of dozens of parallel discovery conversations, the network is one entry point to reach.
A solo practitioner's supplier contacts cap what they can field, and cold-sourcing a new supplier per study is not a realistic use of one person's week. The directory is reach you do not have to go and build first.
Qualifying a supplier you will use once is weeks of work with no residual value. Here the vetting is continuous and observational, so the record is already there the next time a study needs someone new mid-field.
An insights team commissioning reputation-sensitive work needs to know the sample came from named, vetted sources rather than an anonymous pool, so the methodology survives scrutiny from regulators, medical reviewers or the board.
The outcome
Feasibility becomes a network question rather than a “which three suppliers do I happen to know” question. You still choose who to work with, you still negotiate your own rates, and the relationship you form is yours to keep, because nothing sits between your price and the supplier’s invoice.
Finding six named suppliers who hold the cohort is progress right up to the moment you have to send six RFQs, compare six quote formats, negotiate six rates and reconcile six invoices. That coordination is what FieldworkOS takes off the desk.
Together they cover sourcing a study, running it, and protecting what comes back. Nothing here has to be adopted in order.
| If you are | Start with | Because |
|---|---|---|
| Client-side insights | SurveyGuard | Your name is on the data's integrity. |
| Full-service agency | FieldworkOS | Coordination is your daily bottleneck. |
| Independent researcher | FieldworkOS | It is the operations team you do not have. |
| Sample supplier | FieldworkOS | Your partner layer needs a system. |
| Healthcare / specialist | Open Network | Reaching the audience is the hard part. |
Want to see all three on one study rather than product by product? The hard-to-reach sample walkthrough follows a single German healthcare study through six steps, from the shortfall to the reconciled invoice.
The fastest way to judge network reach is against an audience you already failed to source. Tell us the cohort and the market, and we will walk the sourcing question through with you.